Vaccine for Lyme disease needed, doctor says
"Now, in light of the 300,000 cases of Lyme forecast this year by the CDC, there is again wide interest in developing a Lyme vaccine. Several candidates are in the works."
"Researchers from Stony Brook University, Brookhaven National Laboratory, and drug manufacturer Baxter International have developed a promising vaccine. Like LYMErix, this bioengineered vaccine kills the Borrelia bacteria in the gut of the tick before it can be transmitted to humans, but it protects against a broader array of species than the earlier vaccine and against American and European strains of the disease."
"Now, in light of the 300,000 cases of Lyme forecast this year by the CDC, there is again wide interest in developing a Lyme vaccine. Several candidates are in the works."
"Researchers from Stony Brook University, Brookhaven National Laboratory, and drug manufacturer Baxter International have developed a promising vaccine. Like LYMErix, this bioengineered vaccine kills the Borrelia bacteria in the gut of the tick before it can be transmitted to humans, but it protects against a broader array of species than the earlier vaccine and against American and European strains of the disease."
